The Hedgehog Pathway as a Therapeutic Target in Chronic Myeloid Leukemia
Despite the development of therapeutic agents that selectively target cancer cells, relapse driven by acquired drug resistance and resulting treatment failure remains a significant issue. The highly conserved Hedgehog (HH) signaling pathway performs multiple roles in both development and tissue home...
Saved in:
Main Authors: | Andrew Wu (Author), Kelly A. Turner (Author), Adrian Woolfson (Author), Xiaoyan Jiang (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Emerging Therapeutic Strategies for Targeting Chronic Myeloid Leukemia Stem Cells
by: Ahmad Hamad, et al.
Published: (2013) -
Novel targeted therapies in chronic myeloid leukemia
by: Muhammad Sameer Ashaq, et al.
Published: (2024) -
Therapeutic targeting of PARP with immunotherapy in acute myeloid leukemia
by: Xing Bian, et al.
Published: (2024) -
Development and targeted use of nilotinib in chronic myeloid leukemia
by: Carmen Fava, et al.
Published: (2008) -
Advances in targeted therapy for acute myeloid leukemia
by: Jifeng Yu, et al.
Published: (2020)